New in 2021, Market Scope’s “Ophthalmic Deals Report” will be published on a quarterly basis to provide a quarterly view by sector, company, and investor for the past 12 quarters.
The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.
This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.
This report provides a quarterly analysis of ophthalmic fundraising. Transactions raised are categorized by fund use, including new venture, commercial equity, sale of companies, and license payments. Four investment types are analyzed in this report: strategic investors, venture capital, public offerings, and private equity.
A detailed transaction analysis is provided for seven ophthalmic sectors: dry eye, retina, glaucoma, cataract, diagnostic, cornea, and refractive. Key investors and transactions in each sector are included. Deal counts and transaction totals are included for each ophthalmic sector.
Key metrics in this report include companies raising funds, companies making investments, and top funded companies.
Information in this document has been compiled from a variety of primary and secondary sources, including:
Market Scope does its best to triangulate data used in this report by looking for multiple independent sources, checking with executives at companies, and testing information for reasonableness.
2 licensing types are available for this subscription:
SINGLE USER LICENSE
Pay by credit card or by invoice.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.